Abstract
A diagnosis of cirrhosis initiates a shift in the management of chronic liver disease and affects the diagnostic workflow and treatment decision of primary liver cancer. Liver biopsy remains the gold standard for cirrhosis diagnosis, but it is invasive and susceptible to sampling bias and observer variability. Various qualitative and quantitative imaging biomarkers based on ultrasound, CT and MRI have been proposed for noninvasive diagnosis of cirrhosis. Qualitative imaging features are easy to apply but have moderate diagnostic sensitivity. Elastography techniques allow quantitative assessment of liver stiffness and are highly accurate for cirrhosis diagnosis. Ultrasound elastography are widely used in clinical practice, while MR elastography has narrower availability. Although not applicable in clinical practice yet, other quantitative imaging features, including liver surface nodularity, linear and volumetric measurement, extracellular volume fraction, liver enhancement on hepatobiliary phase, and parameters derived from diffusion-weighted imaging, can provide additional information of liver morphology, perfusion, and function, thus may increase diagnosis performance. The introduction of radiomics and deep learning has further improved diagnostic accuracy while reducing subjectivity. Several imaging features may also help to assess liver function and outcomes in patients with cirrhosis. In this review, we summarize the qualitative and quantitative imaging biomarkers for noninvasive cirrhosis diagnosis, and the assessment of liver function and outcomes, and discuss the challenges and future directions in this field.
Similar content being viewed by others
Data availability
The figures are available from the corresponding author, Prof. Bin Song, upon reasonable request.
Abbreviations
- cACLD:
-
compensated advanced chronic liver disease
- ADC:
-
apparent diffusion coefficient
- APRI:
-
aspartate aminotransferase to platelet ratio index
- AUC:
-
area under the curve
- BMI:
-
body mass index
- BSA:
-
body surface area
- CEI:
-
contrast enhancement index
- CRL:
-
caudate to right lobe ratio
- CT:
-
computed tomography
- DALY:
-
disability-adjusted life-year
- DWI:
-
diffusion-weighted imaging
- ECV:
-
extracellular volume fraction
- FIB-4:
-
fibrosis-4 index
- FLIS:
-
functional liver imaging score
- HBP:
-
hepatobiliary phase
- HCC:
-
hepatocellular carcinoma
- ICC:
-
intraclass correlation coefficients
- IVIM:
-
intravoxel incoherent motion
- LSN:
-
liver surface nodularity
- LSVR:
-
liver segmental volume ratio
- MRE:
-
magnetic resonance elastography
- MRI:
-
magnetic resonance imaging
- NAFLD:
-
non-alcoholic fatty liver disease
- NASH:
-
non-alcoholic steatohepatitis
- pSWE:
-
point shear wave elastography
- PHLF:
-
posthepatectomy liver failure
- RE:
-
relative enhancement
- RHVC:
-
right hepatic vein caliber
- ROI:
-
region of interest
- SV:
-
spleen volume
- TE:
-
transient elastography
- TLV:
-
total liver volume
- 2D SWE:
-
two-dimensional shear wave elastography
References
G. D’Amico, A. Morabito, M. D’Amico, L. Pasta, G. Malizia, P. Rebora, M.G. Valsecchi, Clinical states of cirrhosis and competing risks, J Hepatol 68(3) (2018) 563–576.
E.A. Tsochatzis, J. Bosch, A.K. Burroughs, Liver cirrhosis, Lancet 383(9930) (2014) 1749–61.
P. Jepsen, Z.M. Younossi, The global burden of cirrhosis: A review of disability-adjusted life-years lost and unmet needs, J Hepatol 75 Suppl 1 (2021) S3-S13.
N.A. Terrault, A.S.F. Lok, B.J. McMahon, K.M. Chang, J.P. Hwang, M.M. Jonas, R.S. Brown, Jr., N.H. Bzowej, J.B. Wong, Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance, Hepatology 67(4) (2018) 1560–1599.
M.G. Ghany, T.R. Morgan, A.-I.H.C.G. Panel, Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection, Hepatology 71(2) (2020) 686–721.
European Association for the Study of the Liver. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update, J Hepatol 75(3) (2021) 659–689.
V. Chernyak, K.J. Fowler, A. Kamaya, A.Z. Kielar, K.M. Elsayes, M.R. Bashir, Y. Kono, R.K. Do, D.G. Mitchell, A.G. Singal, A. Tang, C.B. Sirlin, Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients, Radiology 289(3) (2018) 816–830.
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma, J Hepatol 69(1) (2018) 182–236.
J.K. Heimbach, L.M. Kulik, R.S. Finn, C.B. Sirlin, M.M. Abecassis, L.R. Roberts, A.X. Zhu, M.H. Murad, J.A. Marrero, AASLD guidelines for the treatment of hepatocellular carcinoma, Hepatology 67(1) (2018) 358–380.
European Association for the Study of the Liver. EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma, J Hepatol 79(1) (2023) 181–208.
M.C. Rousselet, S. Michalak, F. Dupre, A. Croue, P. Bedossa, J.P. Saint-Andre, P. Cales, N. Hepatitis, Sources of variability in histological scoring of chronic viral hepatitis, Hepatology 41(2) (2005) 257–64.
A. Regev, M. Berho, L.J. Jeffers, C. Milikowski, E.G. Molina, N.T. Pyrsopoulos, Z.Z. Feng, K.R. Reddy, E.R. Schiff, Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection, Am J Gastroenterol 97(10) (2002) 2614–8.
R. Cannella, N. Dasyam, S.H. Seo, A. Furlan, A.A. Borhani, Performance of morphologic criteria for the diagnosis of cirrhosis in patients with non-alcoholic steatohepatitis compared to other etiologies of chronic liver disease: effect of level of training and experience, Abdom Radiol (NY) 46(3) (2021) 960–968.
R. Rustogi, J. Horowitz, C. Harmath, Y. Wang, H. Chalian, D.R. Ganger, Z.E. Chen, B.D. Bolster, Jr., S. Shah, F.H. Miller, Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis, J Magn Reson Imaging 35(6) (2012) 1356–64.
S.K. Venkatesh, M. Yin, N. Takahashi, J.F. Glockner, J.A. Talwalkar, R.L. Ehman, Non-invasive detection of liver fibrosis: MR imaging features vs. MR elastography, Abdom Imaging 40(4) (2015) 766–75.
S. Rajesh, A. Mukund, B. Sureka, K. Bansal, M. Ronot, A. Arora, Non-cirrhotic portal hypertension: an imaging review, Abdom Radiol (NY) 43(8) (2018) 1991–2010.
J.H. Kim, Y.D. Kim, M. Lee, B.G. Jun, T.S. Kim, K.T. Suk, S.H. Kang, M.Y. Kim, G.J. Cheon, D.J. Kim, S.K. Baik, D.H. Choi, Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy, J Hepatol 69(5) (2018) 1066–1073.
T. Zhang, G. Zhang, X. Deng, J. Zeng, J. Jin, H. Zeping, M. Wu, R. Zheng, APS (Age, Platelets, 2D Shear-Wave Elastography) Score Predicts Hepatocellular Carcinoma in Chronic Hepatitis B, Radiology 301(2) (2021) 350–359.
A.D. Smith, K.A. Zand, E. Florez, R. Sirous, D. Shlapak, F. Souza, M. Roda, J. Bryan, A. Vasanji, M. Griswold, S.T. Lirette, Liver Surface Nodularity Score Allows Prediction of Cirrhosis Decompensation and Death, Radiology 283(3) (2017) 711–722.
G.A. Kim, Y.S. Lim, S. Han, J. Choi, J.H. Shim, K.M. Kim, H.C. Lee, Y.S. Lee, High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B, Gut 67(5) (2018) 945–952.
A. Colli, M. Fraquelli, M. Andreoletti, B. Marino, E. Zuccoli, D. Conte, Severe liver fibrosis or cirrhosis: accuracy of US for detection–analysis of 300 cases, Radiology 227(1) (2003) 89–94.
M. Friedrich-Rust, M.F. Ong, S. Martens, C. Sarrazin, J. Bojunga, S. Zeuzem, E. Herrmann, Performance of transient elastography for the staging of liver fibrosis: a meta-analysis, Gastroenterology 134(4) (2008) 960–74.
Y.S. Seo, M.Y. Kim, S.U. Kim, B.S. Hyun, J.Y. Jang, J.W. Lee, J.I. Lee, S.J. Suh, S.Y. Park, H. Park, E.U. Jung, B.S. Kim, I.H. Kim, T.H. Lee, S.H. Um, K.H. Han, S.G. Kim, S.K. Paik, J.Y. Choi, S.W. Jeong, Y.J. Jin, K.S. Lee, H.J. Yim, W.Y. Tak, S.G. Hwang, Y.J. Lee, C.H. Lee, D.G. Kim, Y.W. Kang, Y.S. Kim, G. Korean Transient Elastography Study, Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study, Liver Int 35(10) (2015) 2246–55.
F.E. Mozes, J.A. Lee, E.A. Selvaraj, A.N.A. Jayaswal, M. Trauner, J. Boursier, C. Fournier, K. Staufer, R.E. Stauber, E. Bugianesi, R. Younes, S. Gaia, M. Lupsor-Platon, S. Petta, T. Shima, T. Okanoue, S. Mahadeva, W.K. Chan, P.J. Eddowes, G.M. Hirschfield, P.N. Newsome, V.W. Wong, V. de Ledinghen, J. Fan, F. Shen, J.F. Cobbold, Y. Sumida, A. Okajima, J.M. Schattenberg, C. Labenz, W. Kim, M.S. Lee, J. Wiegand, T. Karlas, Y. Yilmaz, G.P. Aithal, N. Palaniyappan, C. Cassinotto, S. Aggarwal, H. Garg, G.J. Ooi, A. Nakajima, M. Yoneda, M. Ziol, N. Barget, A. Geier, T. Tuthill, M.J. Brosnan, Q.M. Anstee, S. Neubauer, S.A. Harrison, P.M. Bossuyt, M. Pavlides, L. Investigators, Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis, Gut 71(5) (2022) 1006–1019.
E.A. Selvaraj, F.E. Mozes, A.N.A. Jayaswal, M.H. Zafarmand, Y. Vali, J.A. Lee, C.K. Levick, L.A.J. Young, N. Palaniyappan, C.H. Liu, G.P. Aithal, M. Romero-Gomez, M.J. Brosnan, T.A. Tuthill, Q.M. Anstee, S. Neubauer, S.A. Harrison, P.M. Bossuyt, M. Pavlides, L. Investigators, Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis, J Hepatol 75(4) (2021) 770–785.
C.S. Pavlov, G. Casazza, D. Nikolova, E. Tsochatzis, C. Gluud, Systematic review with meta-analysis: diagnostic accuracy of transient elastography for staging of fibrosis in people with alcoholic liver disease, Aliment Pharmacol Ther 43(5) (2016) 575–85.
P. Kennedy, M. Wagner, L. Castera, C.W. Hong, C.L. Johnson, C.B. Sirlin, B. Taouli, Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions, Radiology 286(3) (2018) 738–763.
L. Castera, J. Foucher, P.H. Bernard, F. Carvalho, D. Allaix, W. Merrouche, P. Couzigou, V. de Ledinghen, Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations, Hepatology 51(3) (2010) 828–35.
S. Bota, H. Herkner, I. Sporea, P. Salzl, R. Sirli, A.M. Neghina, M. Peck-Radosavljevic, Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis, Liver Int 33(8) (2013) 1138–47.
E. Herrmann, V. de Ledinghen, C. Cassinotto, W.C. Chu, V.Y. Leung, G. Ferraioli, C. Filice, L. Castera, V. Vilgrain, M. Ronot, J. Dumortier, A. Guibal, S. Pol, J. Trebicka, C. Jansen, C. Strassburg, R. Zheng, J. Zheng, S. Francque, T. Vanwolleghem, L. Vonghia, E.K. Manesis, P. Zoumpoulis, I. Sporea, M. Thiele, A. Krag, C. Cohen-Bacrie, A. Criton, J. Gay, T. Deffieux, M. Friedrich-Rust, Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis, Hepatology 67(1) (2018) 260–272.
Y. Lin, H. Li, C. Jin, H. Wang, B. Jiang, The diagnostic accuracy of liver fibrosis in non-viral liver diseases using acoustic radiation force impulse elastography: A systematic review and meta-analysis, PLoS One 15(1) (2020) e0227358.
C. Cassinotto, J. Boursier, A. Paisant, B. Guiu, M. Irles-Depe, C. Canivet, C. Aube, V. de Ledinghen, Transient Versus Two-Dimensional Shear-Wave Elastography in a Multistep Strategy to Detect Advanced Fibrosis in NAFLD, Hepatology 73(6) (2021) 2196–2205.
T.J. Hall, A. Milkowski, B. Garra, P. Carson, M. Palmeri, K. Nightingale, T. Lynch, A. Alturki, M. Andre, S. Audiere, J. Bamber, R. Barr, J. Bercoff, J. Bercoff, M. Bernal, J. Brum, H.W. Chan, S.G. Chen, C. Cohen-Bacrie, M. Couade, A. Daniels, R. DeWall, J. Dillman, R. Ehman, S.F. Franchi-Abella, J. Fromageau, J.L. Gennisson, J.P. Henry, N. Ivancevich, J. Kalin, S. Kohn, J. Kugel, K. Lee, N.L. Liu, T. Loupas, J. Mazernik, S. McAleavey, V. Miette, S. Metz, B.M. Morel, T. Nelson, E. Nordberg, J. Oudry, M. Padwal, N. Rouze, A. Samir, L. Sandrin, J. Schaccitti, C. Schmitt, V. Shamdasani, P.F. Song, P. Switalski, M. Wang, K. Wear, H. Xie, H. Zhao, RSNA/QIBA: Shear wave speed as a biomarker for liver fibrosis staging, Ieee Int Ultra Sym (2013) 397–400.
G. Ferraioli, V.W. Wong, L. Castera, A. Berzigotti, I. Sporea, C.F. Dietrich, B.I. Choi, S.R. Wilson, M. Kudo, R.G. Barr, Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations, Ultrasound Med Biol 44(12) (2018) 2419–2440.
A. Tang, G. Cloutier, N.M. Szeverenyi, C.B. Sirlin, Ultrasound Elastography and MR Elastography for Assessing Liver Fibrosis: Part 2, Diagnostic Performance, Confounders, and Future Directions, AJR Am J Roentgenol 205(1) (2015) 33–40.
S. Gaia, S. Carenzi, A.L. Barilli, E. Bugianesi, A. Smedile, F. Brunello, A. Marzano, M. Rizzetto, Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis, J Hepatol 54(1) (2011) 64–71.
H. Ochi, M. Hirooka, Y. Koizumi, T. Miyake, Y. Tokumoto, Y. Soga, F. Tada, M. Abe, Y. Hiasa, M. Onji, Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases, Hepatology 56(4) (2012) 1271–8.
B. Dong, G. Lyu, Y. Chen, G. Lin, H. Wang, R. Qin, J. Gu, Comparison of two-dimensional shear wave elastography, magnetic resonance elastography, and three serum markers for diagnosing fibrosis in patients with chronic hepatitis B: a meta-analysis, Expert Rev Gastroenterol Hepatol 15(9) (2021) 1077–1089.
G. Xiao, S. Zhu, X. Xiao, L. Yan, J. Yang, G. Wu, Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis, Hepatology 66(5) (2017) 1486–1501.
C.T. Chou, R.C. Chen, W.P. Wu, P.Y. Lin, Y.L. Chen, Prospective Comparison of the Diagnostic Performance of Magnetic Resonance Elastography with Acoustic Radiation Force Impulse Elastography for Pre-operative Staging of Hepatic Fibrosis in Patients with Hepatocellular Carcinoma, Ultrasound Med Biol 43(12) (2017) 2783–2790.
Y.N. Zhang, K.J. Fowler, A. Ozturk, C.K. Potu, A.L. Louie, V. Montes, W.C. Henderson, K. Wang, M.P. Andre, A.E. Samir, C.B. Sirlin, Liver fibrosis imaging: A clinical review of ultrasound and magnetic resonance elastography, J Magn Reson Imaging 51(1) (2020) 25–42.
R. Loomba, J. Cui, T. Wolfson, W. Haufe, J. Hooker, N. Szeverenyi, B. Ang, A. Bhatt, K. Wang, H. Aryafar, C. Behling, M.A. Valasek, G.Y. Lin, A. Gamst, D.A. Brenner, M. Yin, K.J. Glaser, R.L. Ehman, C.B. Sirlin, Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study, Am J Gastroenterol 111(7) (2016) 986 – 94.
Y. Shi, F. Xia, Q.J. Li, J.H. Li, B. Yu, Y. Li, H. An, K.J. Glaser, S. Tao, R.L. Ehman, Q.Y. Guo, Magnetic Resonance Elastography for the Evaluation of Liver Fibrosis in Chronic Hepatitis B and C by Using Both Gradient-Recalled Echo and Spin-Echo Echo Planar Imaging: A Prospective Study, Am J Gastroenterol 111(6) (2016) 823 – 33.
Y. Lee, J.M. Lee, J.E. Lee, K.B. Lee, E.S. Lee, J.H. Yoon, M.H. Yu, J.H. Baek, C.I. Shin, J.K. Han, B.I. Choi, MR elastography for noninvasive assessment of hepatic fibrosis: reproducibility of the examination and reproducibility and repeatability of the liver stiffness value measurement, J Magn Reson Imaging 39(2) (2014) 326 – 31.
M. Yin, K.J. Glaser, J.A. Talwalkar, J. Chen, A. Manduca, R.L. Ehman, Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations, Radiology 278(1) (2016) 114–24.
J. Chen, A.M. Allen, T.M. Therneau, J. Chen, J. Li, S. Hoodeshenas, J. Chen, X. Lu, Z. Zhu, S.K. Venkatesh, B. Song, R.L. Ehman, M. Yin, Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis, Eur Radiol 32(2) (2022) 950–958.
S. Goshima, M. Kanematsu, T. Kobayashi, T. Furukawa, X. Zhang, H. Fujita, H. Watanabe, H. Kondo, N. Moriyama, K.T. Bae, Staging hepatic fibrosis: computer-aided analysis of hepatic contours on gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid-enhanced hepatocyte-phase magnetic resonance imaging, Hepatology 55(1) (2012) 328–9.
D.J. Bae, E.S. Yang, W.S. Park, H.K. Lee, J.S. Song, T.H. Kim, K.H. Yoon, Reproducibility of MRI-derived liver surface nodularity score: analysis of patients with repeated MRI in various scanners, Abdom Radiol (NY) 48(2) (2023) 590–600.
T.H. Kim, Y.R. Kim, C.W. Jeong, H.J. Kim, J.W. Kim, Y.H. Lee, K.H. Yoon, Regional Analysis of Liver Surface Nodularity in a Single Axial MR Image for Staging Liver Fibrosis, J Magn Reson Imaging 56(6) (2022) 1781–1791.
A.D. Smith, C.R. Branch, K. Zand, C. Subramony, H. Zhang, K. Thaggard, R. Hosch, J. Bryan, A. Vasanji, M. Griswold, X. Zhang, Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of Cirrhosis, Radiology 280(3) (2016) 771–81.
M.G. Lubner, D. Jones, A. Said, J. Kloke, S. Lee, P.J. Pickhardt, Accuracy of liver surface nodularity quantification on MDCT for staging hepatic fibrosis in patients with hepatitis C virus, Abdom Radiol (NY) 43(11) (2018) 2980–2986.
P.J. Pickhardt, K. Malecki, J. Kloke, M.G. Lubner, Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis, AJR Am J Roentgenol 207(6) (2016) 1194–1199.
N. De Vos, R. Sartoris, F. Cauchy, P.E. Rautou, V. Vilgrain, M. Ronot, Performance of liver surface nodularity quantification for the diagnosis of portal hypertension in patients with cirrhosis: comparison between MRI with hepatobiliary phase sequences and CT, Abdom Radiol (NY) 45(2) (2020) 365–372.
R. Sartoris, M. Lazareth, A. Nivolli, M. Dioguardi Burgio, V. Vilgrain, M. Ronot, CT-based liver surface nodularity for the detection of clinically significant portal hypertension: defining measurement quality criteria, Abdom Radiol (NY) 45(9) (2020) 2755–2763.
M. Dioguardi Burgio, R. Sartoris, A. Beaufrere, J. Gregory, B. Guiu, C. Guillot, P.E. Rautou, L. Castera, M. Bouattour, V. Paradis, V. Vilgrain, M. Ronot, Liver surface nodularity on non-contrast MRI identifies advanced fibrosis in patients with NAFLD, Eur Radiol 32(3) (2022) 1781–1791.
W.P. Harbin, N.J. Robert, J.T. Ferrucci, Jr., Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis, Radiology 135(2) (1980) 273–83.
H. Awaya, D.G. Mitchell, T. Kamishima, G. Holland, K. Ito, T. Matsumoto, Cirrhosis: modified caudate-right lobe ratio, Radiology 224(3) (2002) 769–74.
O.M. Furusato Hunt, M.G. Lubner, T.J. Ziemlewicz, A. Munoz Del Rio, P.J. Pickhardt, The Liver Segmental Volume Ratio for Noninvasive Detection of Cirrhosis: Comparison With Established Linear and Volumetric Measures, J Comput Assist Tomogr 40(3) (2016) 478–84.
Y. Zhang, X.M. Zhang, J.C. Prowda, H.L. Zhang, C. Sant’anna Henry, G. Shih, J.C. Emond, M.R. Prince, Changes in hepatic venous morphology with cirrhosis on MRI, J Magn Reson Imaging 29(5) (2009) 1085–92.
L.M. Feng, S.J. Lei, X. Zeng, P.Q. Wang, R.T. Chen, J. Wang, X. Sheng, P.M. Shi, Z.L. Yuan, W.F. Xie, The evaluation of non-invasive multi-slice spiral computed tomography-based indices for the diagnosis and prognosis prediction of liver cirrhosis, J Dig Dis 18(8) (2017) 472–479.
P.J. Pickhardt, K. Malecki, O.F. Hunt, C. Beaumont, J. Kloke, T.J. Ziemlewicz, M.G. Lubner, Hepatosplenic volumetric assessment at MDCT for staging liver fibrosis, Eur Radiol 27(7) (2017) 3060–3068.
L.M. Feng, P.Q. Wang, H. Yu, R.T. Chen, J. Wang, X. Sheng, Z.L. Yuan, P.M. Shi, W.F. Xie, X. Zeng, New formula for predicting standard liver volume in Chinese adults, World J Gastroenterol 23(27) (2017) 4968–4977.
T. Kokudo, K. Hasegawa, E. Uldry, Y. Matsuyama, J. Kaneko, N. Akamatsu, T. Aoki, Y. Sakamoto, N. Demartines, Y. Sugawara, N. Kokudo, N. Halkic, A new formula for calculating standard liver volume for living donor liver transplantation without using body weight, J Hepatol 63(4) (2015) 848–54.
M.H. Zissen, Z.J. Wang, J. Yee, R. Aslam, A. Monto, B.M. Yeh, Contrast-enhanced CT quantification of the hepatic fractional extracellular space: correlation with diffuse liver disease severity, AJR Am J Roentgenol 201(6) (2013) 1204–10.
J.A. Luetkens, S. Klein, F. Traber, F.C. Schmeel, A.M. Sprinkart, D.L.R. Kuetting, W. Block, F.E. Uschner, R. Schierwagen, K. Hittatiya, G. Kristiansen, J. Gieseke, H.H. Schild, J. Trebicka, G.M. Kukuk, Quantification of Liver Fibrosis at T1 and T2 Mapping with Extracellular Volume Fraction MRI: Preclinical Results, Radiology 288(3) (2018) 748–754.
S.L. Guo, L.N. Su, Y.N. Zhai, W.M. Chirume, J.Q. Lei, H. Zhang, L. Yang, X.P. Shen, X.X. Wen, Y.M. Guo, The clinical value of hepatic extracellular volume fraction using routine multiphasic contrast-enhanced liver CT for staging liver fibrosis, Clin Radiol 72(3) (2017) 242–246.
K. Tago, J. Tsukada, N. Sudo, K. Shibutani, M. Okada, H. Abe, K. Ibukuro, T. Higaki, T. Takayama, Comparison between CT volumetry and extracellular volume fraction using liver dynamic CT for the predictive ability of liver fibrosis in patients with hepatocellular carcinoma, Eur Radiol (2022).
M.L. Wells, M.R. Moynagh, R.E. Carter, R.A. Childs, C.E. Leitch, J.G. Fletcher, B.M. Yeh, S.K. Venkatesh, Correlation of hepatic fractional extracellular space using gadolinium enhanced MRI with liver stiffness using magnetic resonance elastography, Abdom Radiol (NY) 42(1) (2017) 191–198.
P.A. Kupczyk, N. Mesropyan, A. Isaak, C. Endler, A. Faron, D. Kuetting, A.M. Sprinkart, B. Madler, D. Thomas, U.I. Attenberger, J.A. Luetkens, Quantitative MRI of the liver: Evaluation of extracellular volume fraction and other quantitative parameters in comparison to MR elastography for the assessment of hepatopathy, Magn Reson Imaging 77 (2021) 7–13.
N. Mesropyan, P. Kupczyk, A. Isaak, C. Endler, A. Faron, L. Dold, A.M. Sprinkart, C.C. Pieper, D. Kuetting, U. Attenberger, J.A. Luetkens, Synthetic extracellular volume fraction without hematocrit sampling for hepatic applications, Abdom Radiol (NY) 46(10) (2021) 4637–4646.
Y. Shinagawa, K. Sakamoto, K. Sato, E. Ito, H. Urakawa, K. Yoshimitsu, Usefulness of new subtraction algorithm in estimating degree of liver fibrosis by calculating extracellular volume fraction obtained from routine liver CT protocol equilibrium phase data: Preliminary experience, Eur J Radiol 103 (2018) 99–104.
Y. Nagayama, Y. Kato, T. Inoue, T. Nakaura, S. Oda, M. Kidoh, O. Ikeda, T. Hirai, Liver fibrosis assessment with multiphasic dual-energy CT: diagnostic performance of iodine uptake parameters, Eur Radiol 31(8) (2021) 5779–5790.
J.H. Yoon, J.M. Lee, J.H. Kim, K.B. Lee, H. Kim, S.K. Hong, N.J. Yi, K.W. Lee, K.S. Suh, Hepatic fibrosis grading with extracellular volume fraction from iodine mapping in spectral liver CT, Eur J Radiol 137 (2021) 109604.
K.Y. Elbanna, B. Mansoori, A. Mileto, P. Rogalla, S.G. L, Dual-energy CT in diffuse liver disease: is there a role?, Abdom Radiol (NY) 45(11) (2020) 3413–3424.
N.F. Majeed, M. Braschi Amirfarzan, C. Wald, J.R. Wortman, Spectral detector CT applications in advanced liver imaging, Br J Radiol 94(1123) (2021) 20201290.
U.K. Marri, P. Das, Shalimar, M. Kalaivani, D.N. Srivastava, K.S. Madhusudhan, Noninvasive Staging of Liver Fibrosis Using 5-Minute Delayed Dual-Energy CT: Comparison with US Elastography and Correlation with Histologic Findings, Radiology 298(3) (2021) 600–608.
D. Feier, C. Balassy, N. Bastati, J. Stift, R. Badea, A. Ba-Ssalamah, Liver fibrosis: histopathologic and biochemical influences on diagnostic efficacy of hepatobiliary contrast-enhanced MR imaging in staging, Radiology 269(2) (2013) 460–8.
Y.R. Choi, J.M. Lee, J.H. Yoon, J.K. Han, B.I. Choi, Comparison of magnetic resonance elastography and gadoxetate disodium-enhanced magnetic resonance imaging for the evaluation of hepatic fibrosis, Invest Radiol 48(8) (2013) 607–13.
H.J. Jang, J.H. Min, J.E. Lee, K.S. Shin, K.H. Kim, S.Y. Choi, Assessment of liver fibrosis with gadoxetic acid-enhanced MRI: comparisons with transient elastography, ElastPQ, and serologic fibrosis markers, Abdom Radiol (NY) 44(8) (2019) 2769–2780.
V.C. Obmann, A. Berzigotti, D. Catucci, L. Ebner, C. Grani, J.T. Heverhagen, A. Christe, A.T. Huber, T1 mapping of the liver and the spleen in patients with liver fibrosis-does normalization to the blood pool increase the predictive value?, Eur Radiol 31(6) (2021) 4308–4318.
J.H. Ahn, J.S. Yu, K.S. Park, S.H. Kang, J.H. Huh, J.S. Chang, J.H. Lee, M.Y. Kim, M.D. Nickel, S. Kannengiesser, J.Y. Kim, S.B. Koh, Effect of hepatic steatosis on native T1 mapping of 3T magnetic resonance imaging in the assessment of T1 values for patients with non-alcoholic fatty liver disease, Magn Reson Imaging 80 (2021) 1–8.
Q. Li, T. Chen, N. Shi, W. Ye, M. Yuan, Y. Shi, Quantitative evaluation of hepatic fibrosis by fibro Scan and Gd-EOB-DTPA-enhanced T1 mapping magnetic resonance imaging in chronic hepatitis B, Abdom Radiol (NY) 47(2) (2022) 684–692.
Y. Ding, S.X. Rao, T. Zhu, C.Z. Chen, R.C. Li, M.S. Zeng, Liver fibrosis staging using T1 mapping on gadoxetic acid-enhanced MRI compared with DW imaging, Clin Radiol 70(10) (2015) 1096–103.
L. Yang, Y. Ding, S. Rao, C. Chen, L. Wu, R. Sheng, C. Fu, M. Zeng, Staging liver fibrosis in chronic hepatitis B with T(1) relaxation time index on gadoxetic acid-enhanced MRI: Comparison with aspartate aminotransferase-to-platelet ratio index and FIB-4, J Magn Reson Imaging 45(4) (2017) 1186–1194.
D. Yang, D. Li, J. Li, Z. Yang, Z. Wang, Systematic review: The diagnostic efficacy of gadoxetic acid-enhanced MRI for liver fibrosis staging, Eur J Radiol 125 (2020) 108857.
H. Jiang, J. Chen, R. Gao, Z. Huang, M. Wu, B. Song, Liver fibrosis staging with diffusion-weighted imaging: a systematic review and meta-analysis, Abdom Radiol (NY) 42(2) (2017) 490–501.
Z. Ye, Y. Wei, J. Chen, S. Yao, B. Song, Value of intravoxel incoherent motion in detecting and staging liver fibrosis: A meta-analysis, World J Gastroenterol 26(23) (2020) 3304–3317.
W. Jang, S. Jo, J.S. Song, H.P. Hwang, S.H. Kim, Comparison of diffusion-weighted imaging and MR elastography in staging liver fibrosis: a meta-analysis, Abdom Radiol (NY) 46(8) (2021) 3889–3907.
N. Seo, Y.E. Chung, Y.N. Park, E. Kim, J. Hwang, M.J. Kim, Liver fibrosis: stretched exponential model outperforms mono-exponential and bi-exponential models of diffusion-weighted MRI, Eur Radiol 28(7) (2018) 2812–2822.
J.H. Park, N. Seo, Y.E. Chung, S.U. Kim, Y.N. Park, J.Y. Choi, M.S. Park, M.J. Kim, Noninvasive evaluation of liver fibrosis: comparison of the stretched exponential diffusion-weighted model to other diffusion-weighted MRI models and transient elastography, Eur Radiol 31(7) (2021) 4813–4823.
D. Yoshimaru, T. Miyati, Y. Suzuki, Y. Hamada, N. Mogi, A. Funaki, A. Tabata, A. Masunaga, M. Shimada, M. Tobari, T. Nishino, Diffusion kurtosis imaging with the breath-hold technique for staging hepatic fibrosis: A preliminary study, Magn Reson Imaging 47 (2018) 33–38.
Y. Son, J. Park, J.M. Lee, R. Grimm, I.Y. Kim, Comparison of the Effects of Hepatic Steatosis on Monoexponential DWI, Intravoxel Incoherent Motion Diffusion-weighted Imaging and Diffusion Kurtosis Imaging, Acad Radiol 28 Suppl 1 (2021) S203-S209.
Y.S. Sung, B. Park, H.J. Park, S.S. Lee, Radiomics and deep learning in liver diseases, J Gastroenterol Hepatol 36(3) (2021) 561–568.
K. Wang, X. Lu, H. Zhou, Y. Gao, J. Zheng, M. Tong, C. Wu, C. Liu, L. Huang, T. Jiang, F. Meng, Y. Lu, H. Ai, X.Y. Xie, L.P. Yin, P. Liang, J. Tian, R. Zheng, Deep learning Radiomics of shear wave elastography significantly improved diagnostic performance for assessing liver fibrosis in chronic hepatitis B: a prospective multicentre study, Gut 68(4) (2019) 729–741.
J.C. Wang, R. Fu, X.W. Tao, Y.F. Mao, F. Wang, Z.C. Zhang, W.W. Yu, J. Chen, J. He, B.C. Sun, A radiomics-based model on non-contrast CT for predicting cirrhosis: make the most of image data, Biomark Res 8 (2020) 47.
J. Wang, S. Tang, Y. Mao, J. Wu, S. Xu, Q. Yue, J. Chen, J. He, Y. Yin, Radiomics analysis of contrast-enhanced CT for staging liver fibrosis: an update for image biomarker, Hepatol Int 16(3) (2022) 627–639.
M. Ni, L. Wang, H. Yu, X. Wen, Y. Yang, G. Liu, Y. Hu, Z. Li, Radiomics Approaches for Predicting Liver Fibrosis With Nonenhanced T(1) -Weighted Imaging: Comparison of Different Radiomics Models, J Magn Reson Imaging 53(4) (2021) 1080–1089.
L. He, H. Li, J.A. Dudley, T.C. Maloney, S.L. Brady, E. Somasundaram, A.T. Trout, J.R. Dillman, Machine Learning Prediction of Liver Stiffness Using Clinical and T2-Weighted MRI Radiomic Data, AJR Am J Roentgenol 213(3) (2019) 592–601.
W. Zheng, W. Guo, M. Xiong, X. Chen, L. Gao, Y. Song, D. Cao, Clinic-radiological features and radiomics signatures based on Gd-BOPTA-enhanced MRI for predicting advanced liver fibrosis, Eur Radiol 33(1) (2023) 633–644.
K.J. Choi, J.K. Jang, S.S. Lee, Y.S. Sung, W.H. Shim, H.S. Kim, J. Yun, J.Y. Choi, Y. Lee, B.K. Kang, J.H. Kim, S.Y. Kim, E.S. Yu, Development and Validation of a Deep Learning System for Staging Liver Fibrosis by Using Contrast Agent-enhanced CT Images in the Liver, Radiology 289(3) (2018) 688–697.
S.J. Hectors, P. Kennedy, K.H. Huang, D. Stocker, G. Carbonell, H. Greenspan, S. Friedman, B. Taouli, Fully automated prediction of liver fibrosis using deep learning analysis of gadoxetic acid-enhanced MRI, Eur Radiol 31(6) (2021) 3805–3814.
H.J. Lee, S.B. Hong, N.K. Lee, S. Kim, H.I. Seo, D.U. Kim, S.Y. Han, K.S. Choo, Validation of functional liver imaging scores (FLIS) derived from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Child-Pugh score and FLIS, Eur Radiol 31(11) (2021) 8606–8614.
S. Aslan, U. Eryuruk, M.N. Tasdemir, I.M. Cakir, Determining the efficacy of functional liver imaging score (FLIS) obtained from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Albumin-Bilirubin (ALBI) grade and FLIS, Abdom Radiol (NY) 47(7) (2022) 2325–2334.
N. Luo, X. Huang, Y. Ji, G. Jin, Y. Qin, B. Xiang, D. Su, W. Tang, A functional liver imaging score for preoperative prediction of liver failure after hepatocellular carcinoma resection, Eur Radiol 32(8) (2022) 5623–5632.
N. Bastati, L. Beer, M. Mandorfer, S. Poetter-Lang, D. Tamandl, Y. Bican, M.C. Elmer, H. Einspieler, G. Semmler, B. Simbrunner, M. Weber, J.C. Hodge, F. Vernuccio, C. Sirlin, T. Reiberger, A. Ba-Ssalamah, Does the Functional Liver Imaging Score Derived from Gadoxetic Acid-enhanced MRI Predict Outcomes in Chronic Liver Disease?, Radiology 294(1) (2020) 98–107.
K. Sandrasegaran, E. Cui, R. Elkady, P. Gasparis, G. Borthakur, M. Tann, S. Liangpunsakul, Can functional parameters from hepatobiliary phase of gadoxetate MRI predict clinical outcomes in patients with cirrhosis?, Eur Radiol 28(10) (2018) 4215–4224.
Q. Wang, A. Wang, E. Sparrelid, J. Zhang, Y. Zhao, K. Ma, T.B. Brismar, Predictive value of gadoxetic acid-enhanced MRI for posthepatectomy liver failure: a systematic review, Eur Radiol 32(3) (2022) 1792–1803.
V. Ajmera, B.K. Kim, K. Yang, A.M. Majzoub, T. Nayfeh, N. Tamaki, N. Izumi, A. Nakajima, R. Idilman, M. Gumussoy, D.K. Oz, A. Erden, N.E. Quach, X. Tu, X. Zhang, M. Noureddin, A.M. Allen, R. Loomba, Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants, Gastroenterology 163(4) (2022) 1079–1089 e5.
M. Pons, S. Rodriguez-Tajes, J.I. Esteban, Z. Marino, V. Vargas, S. Lens, M. Buti, S. Augustin, X. Forns, B. Minguez, J. Genesca, Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals, J Hepatol 72(3) (2020) 472–480.
R. Loomba, D.Q. Huang, A.J. Sanyal, Q.M. Anstee, M. Trauner, E.J. Lawitz, D. Ding, L. Ma, C. Jia, A. Billin, R.S. Huss, C. Chung, Z. Goodman, V.W. Wong, T. Okanoue, M. Romero-Gomez, M.F. Abdelmalek, A. Muir, N. Afdhal, J. Bosch, S. Harrison, Z.M. Younossi, R.P. Myers, Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis, Gut 72(3) (2023) 581–589.
J.G. Abraldes, C. Bureau, H. Stefanescu, S. Augustin, M. Ney, H. Blasco, B. Procopet, J. Bosch, J. Genesca, A. Berzigotti, I. Anticipate, Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study, Hepatology 64(6) (2016) 2173–2184.
R. de Franchis, J. Bosch, G. Garcia-Tsao, T. Reiberger, C. Ripoll, V.I.I.F. Baveno, Baveno VII - Renewing consensus in portal hypertension, J Hepatol 76(4) (2022) 959–974.
Ludwig DR, Fraum TJ, Ballard DH, Narra VR, Shetty AS. Imaging Biomarkers of Hepatic Fibrosis: Reliability and Accuracy of Hepatic Periportal Space Widening and Other Morphologic Features on MRI. AJR Am J Roentgenol 216 (5) (2021):1229–1239.
Chow KU, Luxembourg B, Seifried E, Bonig H. Spleen Size Is Significantly Influenced by Body Height and Sex: Establishment of Normal Values for Spleen Size at US with a Cohort of 1200 Healthy Individuals. Radiology 279 (1) (2016):306–313.
Pozo AL, Godfrey EM, Bowles KM. Splenomegaly: investigation, diagnosis and management. Blood Rev 23 (3) (2009):105–111.
Sigrist RMS, Liau J, Kaffas AE, Chammas MC, Willmann JK. Ultrasound Elastography: Review of Techniques and Clinical Applications. Theranostics 7 (5) (2017):1303–1329.
Acknowledgements
Not applicable.
Funding
This study was funded by the National Natural Science Foundation of China (Grant No. 82101997, 81971571), the Science and Technology Support Program of Sichuan Province (Grant No. 2022YFS0072) and the 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University (Grant No. ZYGD22004).
Author information
Authors and Affiliations
Contributions
Conceptualization: TYZ. Funding acquisition: JC, HYJ, BS. Project administration: HYJ, BS. Supervision: HYJ, BS. Visualization: TYZ, YLQ, JC, JY, HLY. Writing-original draft: TYZ. Writing-review & editing: TYZ, YLQ, JC, JY, HLY, HYJ, BS.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zheng, T., Qu, Y., Chen, J. et al. Noninvasive diagnosis of liver cirrhosis: qualitative and quantitative imaging biomarkers. Abdom Radiol 49, 2098–2115 (2024). https://doi.org/10.1007/s00261-024-04225-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-024-04225-8